Lumexa (NASDAQ: LMRI) legal chief to resign, gets $450k transition pay

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. reported that its Chief Legal Officer and Corporate Secretary, Julie Szeker, submitted her resignation effective March 13, 2026. The company stated that her resignation is not due to any disagreement over operations, policies or practices and has begun a search for a successor.

Under a transition letter agreement, Ms. Szeker will receive a $450,000 transition payment and up to 12 months of subsidized healthcare coverage, subject to a release of claims and compliance with the agreement. She will also receive an annual bonus of $250,000 related to 2025 performance, payable at the same time as bonuses to other employees.

Insights

Corporate governance analyst

Lumexa’s chief legal officer plans an orderly, compensated exit.

The company disclosed that Chief Legal Officer and Corporate Secretary Julie Szeker will resign effective March 13, 2026. The filing explicitly notes her departure is not the result of any disagreement regarding operations, policies or practices, which reduces the risk that the exit reflects underlying disputes or compliance concerns.

A transition letter agreement grants a $450,000 transition payment, up to 12 months of subsidized healthcare coverage, and a $250,000 bonus tied to 2025 performance, contingent on her release of claims and ongoing compliance. These terms look like a negotiated separation package designed to support a smooth handover of responsibilities while the company runs a process to identify a successor.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

What leadership change did Lumexa Imaging Holdings (LMRI) disclose?

Lumexa Imaging Holdings, Inc. reported that its Chief Legal Officer and Corporate Secretary, Julie Szeker, submitted her resignation effective March 13, 2026.

Did Julie Szeker resign from LMRI due to a disagreement with the company?

No. The company stated that Ms. Szeker’s resignation was not the result of any disagreement with Lumexa on matters relating to its operations, policies or practices.

What transition payments will LMRI’s departing chief legal officer receive?

Under a transition agreement, Ms. Szeker will receive a $450,000 transition payment and up to 12 months of subsidized healthcare coverage, subject to her signing and not revoking a release of claims and complying with the agreement.

Is LMRI paying a bonus to Julie Szeker related to 2025 performance?

Yes. Subject to her compliance with the transition agreement, Ms. Szeker will receive an annual bonus of $250,000 relating to 2025 performance, paid at the same time as bonuses to other employees.

How is Lumexa Imaging Holdings handling succession after the CLO’s resignation?

Lumexa has initiated a process to identify a successor to Chief Legal Officer and Corporate Secretary Julie Szeker to support an orderly transition.

Where can investors find the full terms of LMRI’s transition agreement with Julie Szeker?

The transition letter agreement with Ms. Szeker is filed as Exhibit 10.1 and is incorporated by reference, providing the complete terms beyond the summarized key payments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 01/15/2026 - 06:48 AM Learn about SEC filing dates

false 0002071288 0002071288 2026-01-12 2026-01-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): January 12, 2026

Lumexa Imaging Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware		001-43010		41-2605845
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

4200 Six Forks Road
Suite 1000
Raleigh, North Carolina		27609
(Address of Principal Executive Offices)		(Zip Code)

(919) 763-1100

(Registrant’s telephone number, including area code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, $0.001 par value per share		LMRI		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 12, 2026, Ms. Julie Szeker, Chief Legal Officer and Corporate Secretary of Lumexa Imaging Holdings, Inc. (the “Company”) submitted her resignation to the Company, effective March 13, 2026. Ms. Szeker’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company has initiated a process to identify a successor.

To support the transition of her duties, the Company and Ms. Szeker entered into a transition letter agreement (the “Transition Agreement”) which provides for a transition payment of $450,000 and up to 12 months of subsidized healthcare coverage, with such payments subject to Ms. Szeker’s execution and non-revocation of a release of claims in favor of the Company and compliance with the terms of the Transition Agreement. In addition, subject to Ms. Szeker’s compliance with the terms of the Transition Agreement, Ms. Szeker will receive an annual bonus of $250,000 relating to 2025 performance and which will be paid at the same time annual bonuses are paid to other employees of the Company.

The foregoing is only a summary of the Transition Agreement and does not purport to be complete, and is qualified in its entirety by reference to the Transition Agreement filed as Exhibit 10.1 hereto and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
10.1		Transition Letter Agreement, dated as of January 13, 2026, between Lumexa Imaging Holdings, Inc. and Julie Szeker
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				LUMEXA IMAGING HOLDINGS, INC.
				By:		/s/ Caitlin Zulla
Date: January 15, 2026				Name:		Caitlin Zulla
				Title:		Chief Executive Officer